by Devices and Pharma | May 5, 2024 | FDA_Programs, Industry Information, Pharmaceuticals, Product-Innovation, Products_biologics, Products_Devices, Products_Drugs, Reg_Products, US-FDA
FDA's Orphan Drug Program To encourage the development of drugs and biologics for rare diseases or conditions Home About Consumer Medical Devices Pharma AI Regulatory Quality QMSR Central News Enforcement Alerts Innovation Contact Expedite Development of New Orphan...
by Devices and Pharma | May 5, 2024 | FDA_Programs, Industry Information, Pharmaceuticals, US-FDA
Rare Pediatric Disease Priority Review Voucher (PRV) program To expedite the review and approval of pediatric disease therapies Home About Consumer News Food and Beverage Supplements Cosmetics Regulatory Medical Devices Pharma Biologics Combination Products In Vitro...
by Devices and Pharma | May 5, 2024 | FDA_Legislation, Industry Information, US-FDA
Navigating Complex Regulations History of Congressional Legislation for FDA Several significant congressional legislative actions have directly affected the establishment, oversight authority, and processes of the US Food and Drug Administration (FDA). As a component...
by Devices and Pharma | May 3, 2024 | Industry Information, Med-Devices, Pharmaceuticals, US-FDA
Navigating Complex Regulations Regulatory Guidance for Medical Devices & Pharmaceuticals At Medical Devices and Pharma, we specialize in providing top-tier regulatory consulting services tailored to the medical device and pharmaceutical industries. Our deep...
by Devices and Pharma | May 3, 2024 | FDA Approvals, Industry News, New Drugs, New Pharma Products, Pharmaceuticals, Product-Innovation, US-FDA
Drug Innovation - Tisotumab vedotin-tftv, marketed as Tivdak For Recurrent or Metastatic Cervical Cancer Home About Consumer Medical Devices Pharma AI Regulatory Quality News Enforcement Alerts Innovation Contact Product Approval for Cervical Cancer Drug Exciting...
